<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04608032</url>
  </required_header>
  <id_info>
    <org_study_id>10477M-NARCIS</org_study_id>
    <nct_id>NCT04608032</nct_id>
  </id_info>
  <brief_title>NARCIS COGNITIVE FOR COGNITIVE DISORDERS OF SCHIZOPHRENIA</brief_title>
  <acronym>NARCIS</acronym>
  <official_title>Neuropsychological Assessment of Remediation for Cognitive Impairment in Schizophr√©nie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de Ville-Evrard, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de Ville-Evrard, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of a cognitive remediation program designed for patients&#xD;
      suffering from a schizophrenia spectrum disorder ; on neurocognitive, social cognitive and&#xD;
      metacognitive functions. In this double-blind (patients, outcomes assessors) controlled&#xD;
      randomized trial the investigators compare patients receiving Ecological Cognitive training&#xD;
      program for schizophrenia spectrum disorder [ECo-Sz] to patients benefiting from&#xD;
      recovery-oriented therapy [ThOR]. Patients are treated for two months and monitored for four&#xD;
      months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the specific therapeutic efficacy of the Ecological Cognitive training program&#xD;
      for schizophrenia spectrum disorder [ECo-Sz] on neurocognitive deficits, social cognition and&#xD;
      metacognition deficits of patients with a schizophrenia spectrum disorder.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 8, 2020</start_date>
  <completion_date type="Anticipated">September 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 8, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The first group is about cognitive remediation therapy (ECo-Sz). The second group is about recovery oriented therapy (ThOR).</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mini-500</measure>
    <time_frame>pre-inclusion</time_frame>
    <description>The Mini International Neuropsychiatric Interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CTQ</measure>
    <time_frame>pre-inclusion</time_frame>
    <description>Childhood Trauma questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PANSS</measure>
    <time_frame>pre-inclusion</time_frame>
    <description>Positive and Negative Syndrome Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EESEP</measure>
    <time_frame>First week</time_frame>
    <description>Self-Efficacity Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EESEP</measure>
    <time_frame>Ten week</time_frame>
    <description>Self-Efficacity Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EESEP</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Self-Efficacity Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EESEP</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Self-Efficacity Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF</measure>
    <time_frame>First week</time_frame>
    <description>Functional Impact Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF</measure>
    <time_frame>Ten week</time_frame>
    <description>Functional Impact Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Functional Impact Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Functional Impact Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF-CS</measure>
    <time_frame>First week</time_frame>
    <description>Functional Impact Scale for Social Cognition disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF-CS</measure>
    <time_frame>Ten week</time_frame>
    <description>Functional Impact Scale for Social Cognition disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF-CS</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Functional Impact Scale for Social Cognition disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ERF-CS</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Functional Impact Scale for Social Cognition disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCQ-30</measure>
    <time_frame>First week</time_frame>
    <description>Short French Meta-Cognitions Questionnaire (MCQ-30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCQ-30</measure>
    <time_frame>Ten week</time_frame>
    <description>Short French Meta-Cognitions Questionnaire (MCQ-30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCQ-30</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Short French Meta-Cognitions Questionnaire (MCQ-30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MCQ-30</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Short French Meta-Cognitions Questionnaire (MCQ-30)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QFS</measure>
    <time_frame>First week</time_frame>
    <description>Social Functioning Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QFS</measure>
    <time_frame>Ten week</time_frame>
    <description>Social Functioning Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QFS</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Social Functioning Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QFS</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Social Functioning Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAIQ</measure>
    <time_frame>First week</time_frame>
    <description>Self-Appraisal of Illness Questionnaire (SAIQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAIQ</measure>
    <time_frame>Ten week</time_frame>
    <description>Self-Appraisal of Illness Questionnaire (SAIQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAIQ</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Self-Appraisal of Illness Questionnaire (SAIQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAIQ</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Self-Appraisal of Illness Questionnaire (SAIQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCS</measure>
    <time_frame>First week</time_frame>
    <description>Revised Self-Consciousness Scale (SCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCS</measure>
    <time_frame>Ten week</time_frame>
    <description>Revised Self-Consciousness Scale (SCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCS</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Revised Self-Consciousness Scale (SCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SCS</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Revised Self-Consciousness Scale (SCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SDS</measure>
    <time_frame>First week</time_frame>
    <description>Social Desirability Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SDS</measure>
    <time_frame>Ten week</time_frame>
    <description>Social Desirability Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SDS</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Social Desirability Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SDS</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Social Desirability Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STORI</measure>
    <time_frame>First week</time_frame>
    <description>Stage of Recovery Instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STORI</measure>
    <time_frame>Ten week</time_frame>
    <description>Stage of Recovery Instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STORI</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Stage of Recovery Instrument</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STORI</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Stage of Recovery Instrument</description>
  </secondary_outcome>
  <other_outcome>
    <measure>GREFEX battery</measure>
    <time_frame>First week</time_frame>
    <description>GREFEX battery Stroop Test, Trail Making Test, Verbal Fluency Neuropsychological battery test assessing executive function</description>
  </other_outcome>
  <other_outcome>
    <measure>GREFEX battery</measure>
    <time_frame>Ten week</time_frame>
    <description>GREFEX battery Stroop Test, Trail Making Test, Verbal Fluency Neuropsychological battery test assessing executive function</description>
  </other_outcome>
  <other_outcome>
    <measure>GREFEX battery</measure>
    <time_frame>Eighteen week</time_frame>
    <description>GREFEX battery Stroop Test, Trail Making Test, Verbal Fluency Neuropsychological battery test assessing executive function</description>
  </other_outcome>
  <other_outcome>
    <measure>GREFEX battery</measure>
    <time_frame>Twenty six week</time_frame>
    <description>GREFEX battery Stroop Test, Trail Making Test, Verbal Fluency Neuropsychological battery test assessing executive function</description>
  </other_outcome>
  <other_outcome>
    <measure>FAUX-PAS Test</measure>
    <time_frame>First week</time_frame>
    <description>A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters.</description>
  </other_outcome>
  <other_outcome>
    <measure>FAUX-PAS Test</measure>
    <time_frame>Ten week week</time_frame>
    <description>A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters.</description>
  </other_outcome>
  <other_outcome>
    <measure>FAUX-PAS Test</measure>
    <time_frame>Eighteen week week</time_frame>
    <description>A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters.</description>
  </other_outcome>
  <other_outcome>
    <measure>FAUX-PAS Test</measure>
    <time_frame>Twenty six week</time_frame>
    <description>A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Rey/Taylor complex figure test</measure>
    <time_frame>First week</time_frame>
    <description>The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Rey/Taylor complex figure test</measure>
    <time_frame>Ten week</time_frame>
    <description>The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Rey/Taylor complex figure test</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Rey/Taylor complex figure test</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory.</description>
  </other_outcome>
  <other_outcome>
    <measure>Go/NoGo test</measure>
    <time_frame>First week</time_frame>
    <description>The test is used to measure capacity for sustained attention, inhibition and response control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Go/NoGo test</measure>
    <time_frame>Ten week</time_frame>
    <description>The test is used to measure capacity for sustained attention, inhibition and response control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Go/NoGo test</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The test is used to measure capacity for sustained attention, inhibition and response control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Go/NoGo test</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The test is used to measure capacity for sustained attention, inhibition and response control.</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Logical Memory</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Logical Memory</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Logical Memory</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Logical Memory</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Symbol Memory</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Symbol Memory</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Symbol Memory</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>MEM IV Symbol Memory</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of the Weschler Memory Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>The Balloon Analogue Risk Task</measure>
    <time_frame>First week</time_frame>
    <description>The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Balloon Analogue Risk Task</measure>
    <time_frame>Ten week</time_frame>
    <description>The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Balloon Analogue Risk Task</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.</description>
  </other_outcome>
  <other_outcome>
    <measure>The Balloon Analogue Risk Task</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The Balloon Analogue Risk Task (BART) is a computerized measure of risk taking behavior.</description>
  </other_outcome>
  <other_outcome>
    <measure>D2 Test</measure>
    <time_frame>First week</time_frame>
    <description>The test is neuropsychological measure of selective and sustained attention and visual scanning speed.</description>
  </other_outcome>
  <other_outcome>
    <measure>D2 Test</measure>
    <time_frame>Ten week</time_frame>
    <description>The test is neuropsychological measure of selective and sustained attention and visual scanning speed.</description>
  </other_outcome>
  <other_outcome>
    <measure>D2 Test</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The test is neuropsychological measure of selective and sustained attention and visual scanning speed.</description>
  </other_outcome>
  <other_outcome>
    <measure>D2 Test</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The test is neuropsychological measure of selective and sustained attention and visual scanning speed.</description>
  </other_outcome>
  <other_outcome>
    <measure>ToM-15</measure>
    <time_frame>First week</time_frame>
    <description>The test is a task assessing theory of mind abilities. you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location.</description>
  </other_outcome>
  <other_outcome>
    <measure>ToM-15</measure>
    <time_frame>Ten week</time_frame>
    <description>The test is a task assessing theory of mind abilities. you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location.</description>
  </other_outcome>
  <other_outcome>
    <measure>ToM-15</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The test is a task assessing theory of mind abilities. you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location.</description>
  </other_outcome>
  <other_outcome>
    <measure>ToM-15</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The test is a task assessing theory of mind abilities. you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location.</description>
  </other_outcome>
  <other_outcome>
    <measure>Tower of Hanoi</measure>
    <time_frame>First week</time_frame>
    <description>The Tower of Hanoi is used to measure capacity on problem solving and planning, self-consciousness and control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Tower of Hanoi</measure>
    <time_frame>Ten week</time_frame>
    <description>The Tower of Hanoi is used to measure capacity on problem solving and planning, self-consciousness and control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Tower of Hanoi</measure>
    <time_frame>Eighteen week</time_frame>
    <description>The Tower of Hanoi is used to measure capacity on problem solving and planning, self-consciousness and control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Tower of Hanoi</measure>
    <time_frame>Twenty six week</time_frame>
    <description>The Tower of Hanoi is used to measure capacity on problem solving and planning, self-consciousness and control.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cubes Subtest</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Cubes Subtest</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Cubes Subtest</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Cubes Subtest</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Matrices Subtest</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Matrices Subtest</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Matrices Subtest</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Matrices Subtest</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Puzzle Subtest</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Puzzle Subtest</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Puzzle Subtest</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Puzzle Subtest</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Similiraties Subtest</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Similiraties Subtest</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Similiraties Subtest</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Similiraties Subtest</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Memory Subtest</measure>
    <time_frame>First week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Memory Subtest</measure>
    <time_frame>Ten week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Memory Subtest</measure>
    <time_frame>Eighteen week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <other_outcome>
    <measure>Working Memory Subtest</measure>
    <time_frame>Twenty six week</time_frame>
    <description>Composite score of Weschler Adult Intelligence Scale - fourth edition</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Schizophrenia Disorder</condition>
  <arm_group>
    <arm_group_label>Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz]</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>to inform the patient about cognitive impairments and their repercussions ; to train the patient in problem-solving skills through exercices ; to implement strategies in daily life. Duration : two month. Frequency : Two one hour individual sessions and one hour of at-home training per week. Modalities : pen and papers exercices (tools (token, cards, maps and chessboard). Modules : Psychoeducation, Attention, Memory, Executive functions, Social cognition and metacognition, Functional impairments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>[THoR] Recovery-Oriented Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Individual psychotherapy sessions focussing on autonomy in daily life, management of mood disorders' and functional impact, social skills, motivation and the regulation of sleep and daily activities</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>[Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder</intervention_name>
    <description>The first group will have [Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder</description>
    <arm_group_label>Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz]</arm_group_label>
    <other_name>[Eco-Sz]</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recovery-Oriented Therapy</intervention_name>
    <description>The second group will have [THoR] Recovery-Oriented Therapy</description>
    <arm_group_label>[THoR] Recovery-Oriented Therapy</arm_group_label>
    <other_name>[THoR]</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Schizophrenia Disorder diagnosis, according to Diagnostic and Statistical Manual of&#xD;
             mental disorders - Fifth edition (DSM-V) - Patient stabilized in terms of positive and&#xD;
             negative symptomatology (absence or presence of weak positive and negative symptoms)&#xD;
&#xD;
          -  Positive and Negative stable symptoms (no or few positive and negative symptoms)&#xD;
&#xD;
          -  Stable and effective minimum dose of medication (antipsychotic) for the last three&#xD;
             months&#xD;
&#xD;
          -  Cognitive complaint expressed by the patient&#xD;
&#xD;
          -  Informed consent form read, initialed and signed&#xD;
&#xD;
          -  Understanding of spoken and read French&#xD;
&#xD;
          -  Patient registered on the social welfare system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other diagnosis at the forefront than Schizophrenia of the DSM-V&#xD;
&#xD;
          -  Medical history neurological disorder resulting in hospitalization&#xD;
&#xD;
          -  Acute episode in the last three month&#xD;
&#xD;
          -  Somatic disorders resulting in cognitive impairment&#xD;
&#xD;
          -  Engagement in a research protocol either currently or over the last month&#xD;
&#xD;
          -  Neuropsychological assessment evaluation during the last six month&#xD;
&#xD;
          -  Patients under the protection of a conservator (simple or reinforced)&#xD;
&#xD;
          -  Individuals in vulnerable circumstances&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cl√©mence ISAAC, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>URC EPS Ville Evrard</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ch Ville Evrard</name>
      <address>
        <city>Neuilly-sur-Marne</city>
        <zip>93330</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>URC Ville Evrard</name>
      <address>
        <city>Neuilly-sur-Marne</city>
        <zip>93330</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>October 23, 2020</last_update_submitted>
  <last_update_submitted_qc>October 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre hospitalier de Ville-Evrard, France</investigator_affiliation>
    <investigator_full_name>Cl√©mence ISAAC</investigator_full_name>
    <investigator_title>psychologist</investigator_title>
  </responsible_party>
  <keyword>Schizophrenia, neurocognition, cognition sociale, metacognition, cognitive remediation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

